These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33785979)

  • 41. A simulation-based analysis for effective distribution of COVID-19 vaccines: A case study in Norway.
    Sun X; Andoh EA; Yu H
    Transp Res Interdiscip Perspect; 2021 Sep; 11():100453. PubMed ID: 34458722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
    Jadhav S; Gautam M; Gairola S
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perspective of vaccine manufacturers on financing pediatric and adolescent vaccines in the United States.
    Shen AK; Rodewald LE; Birkhead GS
    Pediatrics; 2009 Dec; 124 Suppl 5():S540-7. PubMed ID: 19948586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Panel discussion on vaccine development to meet U.S. and international needs. Strategies for reducing the disincentives to HIV vaccine development: description of a successful public-private sector international collaboration.
    Bronnenkant L
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S311-3. PubMed ID: 7865329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy.
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934625. PubMed ID: 34483336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
    Raj S; Ogola G; Han J
    Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pursuing Value-Based Prices for Drugs: A Comprehensive Comparison of State Prescription Drug-Pricing Boards.
    Bendicksen L; Rome BN; Avorn J; Kesselheim AS
    Milbank Q; 2021 Dec; 99(4):1162-1197. PubMed ID: 34375015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study.
    Bernardi FF; Mascolo A; Sarno M; Capoluongo N; Trama U; Ruggiero R; Sportiello L; Fusco GM; Bisogno M; Coscioni E; Iervolino A; Di Micco P; Capuano A; Perrella A
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
    Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
    Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.
    Taboe HB; Asare-Baah M; Iboi EA; Ngonghala CN
    Math Biosci; 2023 Jun; 360():108981. PubMed ID: 36803672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States.
    Gorenflo MP; Davis PB; Kaelber DC; Xu R
    medRxiv; 2023 Feb; ():. PubMed ID: 36824915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Media Discourse Regarding COVID-19 Vaccinations for Children Aged 5 to 11 Years in Australia, Canada, the United Kingdom, and the United States: Comparative Analysis Using the Narrative Policy Framework.
    Chadwick VL; Saich F; Freeman J; Martiniuk A
    JMIR Form Res; 2024 Apr; 8():e38761. PubMed ID: 36383344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Airline stock markets reaction to the COVID-19 outbreak and vaccines: An event study.
    Martins AM; Cró S
    J Air Transp Manag; 2022 Oct; 105():102281. PubMed ID: 36034526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 Vaccines, Healthcare Policies and Stock Markets: Are There Winners and Losers?
    Diaz RF; Herrador-Alcaide TC; Sanchez-Robles B
    Risk Manag Healthc Policy; 2023; 16():971-989. PubMed ID: 37256165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
    Fraiman J; Erviti J; Jones M; Greenland S; Whelan P; Kaplan RM; Doshi P
    Vaccine; 2022 Sep; 40(40):5798-5805. PubMed ID: 36055877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Public health impact of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in the first year of rollout in the United States.
    Di Fusco M; Marczell K; Deger KA; Moran MM; Wiemken TL; Cane A; de Boisvilliers S; Yang J; Vaghela S; Roiz J
    J Med Econ; 2022; 25(1):605-617. PubMed ID: 35574613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of COVID-19 Vaccines Approved in the United States of America for Emergency Use.
    Vasireddy D; Atluri P; Malayala SV; Vanaparthy R; Mohan G
    J Clin Med Res; 2021 Apr; 13(4):204-213. PubMed ID: 34007358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.